Spectrofluorometric determination of fluvoxamine in dosage forms, spiked plasma, and real human plasma by derivatization with fluorescamineEL-ENANY, Nahed.Journal of AOAC International. 2007, Vol 90, Num 2, pp 376-383, issn 1060-3271, 8 p.Article

Efficacy and safety of fluvoxamine in body dysmorphic disorderPHILLIPS, K. A; DWIGHT, M. M; MCELROY, S. L et al.The Journal of clinical psychiatry. 1998, Vol 59, Num 4, pp 165-171, issn 0160-6689Conference Paper

Patterns of mood variation during antidepressant treatmentBENEDETTI, F; BARBINI, B; CAMPORI, E et al.Journal of affective disorders. 1998, Vol 49, Num 2, pp 133-139, issn 0165-0327Article

An open clinical trial of fluvoxamine treatment of psychogenic excoriationARNOLD, L. M; MUTASIM, D. F; DWIGHT, M. M et al.Journal of clinical psychopharmacology. 1999, Vol 19, Num 1, pp 15-18, issn 0271-0749Article

Fluvoxamine for somatoform disorders : An open trialNOYES, R. JR; HAPPEL, R. L; MULLER, B. A et al.General hospital psychiatry. 1998, Vol 20, Num 6, pp 339-344, issn 0163-8343Article

Short-term single-blind fluvoxamine treatment of pathological gamblingHOLLANDER, E; DECARIA, C. M; MARI, E et al.The American journal of psychiatry. 1998, Vol 155, Num 12, pp 1781-1783, issn 0002-953XArticle

Perspectives on fluvoxamine therapyThe Journal of clinical psychiatry. 1997, Vol 58, issn 0160-6689, 54 p., SUP5Conference Proceedings

Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder: A Randomized, Double-Blind, Placebo-Controlled TrialASKARI, Neda; MOIN, Mahdieh; HAJIAGHAEE, Reza et al.CNS drugs. 2012, Vol 26, Num 10, pp 883-892, issn 1172-7047, 10 p.Article

Selective serotonin re-uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatmentTEICHERT, Martina; VISSER, Loes E; UITTERLINDEN, Andrė G et al.British journal of clinical pharmacology. 2011, Vol 72, Num 5, pp 798-805, issn 0306-5251, 8 p.Article

Involvement of the 5-HT_1A receptor in the anti-immobility effects of fluvoxamine in the forced swimming test and mouse strain differences in 5-HT_1A receptor bindingSUGIMOTO, Yumi; FURUTANI, Sachiko; KAJIWARA, Yoshinobu et al.European journal of pharmacology. 2010, Vol 629, Num 1-3, pp 53-57, issn 0014-2999, 5 p.Article

Association analysis of Group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese populationTSUNOKA, Tomoko; KISHI, Taro; OZAKI, Norio et al.Progress in neuro-psychopharmacology & biological psychiatry. 2009, Vol 33, Num 5, pp 875-879, issn 0278-5846, 5 p.Article

Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-anatysisOMORI, I. M; WATANABE, N; NAKAGAWA, A et al.Journal of psychopharmacology (Oxford). 2009, Vol 23, Num 5, pp 539-550, issn 0269-8811, 12 p.Article

Impact of Ovarian Hormones on the Modulation of the Serotonin Transporter by FluvoxamineBENMANSOUR, Saloua; PIOTROWSKI, Jonathan P; ALTAMIRANO, Alfonso V et al.Neuropsychopharmacology (New York, NY). 2009, Vol 34, Num 3, pp 555-564, issn 0893-133X, 10 p.Article

Pharmacokinetic-pharmacodynamic modelling of fluvoxamine 5-HT transporter occupancy in rat frontal cortexGELDOF, M; FREIJER, J. I; VAN BEIJSTERVELDT, L et al.British journal of pharmacology. 2008, Vol 154, Num 6, pp 1369-1378, issn 0007-1188, 10 p.Article

The effect of fluvoxamine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjectsKADOKURA, Takeshi; DEN ADEL, Martin; KRAUWINKEL, Walter J. J et al.European journal of clinical pharmacology. 2008, Vol 64, Num 7, pp 691-695, issn 0031-6970, 5 p.Article

Antidepressants inhibit interferon-γ-induced microglial production of IL-6 and nitric oxideHASHIOKA, Sadayuki; KLEGERIS, Andis; MONJI, Akira et al.Experimental neurology (Print). 2007, Vol 206, Num 1, pp 33-42, issn 0014-4886, 10 p.Article

Fluvoxamine treatment and D₂ receptors : a pet study on OCD drug-naïve patientsMORESCO, Rosa Maria; PIETRA, Lucia; FAZIO, Ferruccio et al.Neuropsychopharmacology (New York, NY). 2007, Vol 32, Num 1, pp 197-205, issn 0893-133X, 9 p.Article

High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine : A positron emission tomography study using [¹¹C]SA4503ISHIKAWA, Masatomo; ISHIWATA, Kiichi; SHIRAYAMA, Yukihiko et al.Biological psychiatry (1969). 2007, Vol 62, Num 8, pp 878-883, issn 0006-3223, 6 p.Article

Phencyclidine -induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine : Role of sigma-I receptorsHASHIMOTO, Kenji; FUJITA, Yuko; IYO, Masaomi et al.Neuropsychopharmacology (New York, NY). 2007, Vol 32, Num 3, pp 514-521, issn 0893-133X, 8 p.Article

Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype statusUNO, Tsukasa; SHIMIZU, Mikiko; YASUI-FURUKORI, Norio et al.British journal of clinical pharmacology. 2006, Vol 61, Num 3, pp 309-314, issn 0306-5251, 6 p.Article

Sensitive capillary GC-MS-SIM determination of selective serotonin reuptake inhibitors : Reliability evaluation by validation and robustness studyBERZAS NEVADO, Juan José; VILLASENOR LLERENA, Maria Jesus; GUIBERTEAU CABANILLAS, Carmen et al.Journal of separation science. 2006, Vol 29, Num 1, pp 103-113, issn 1615-9306, 11 p.Article

Electrophysiological and neurochemical characterization of the effect of repeated treatment with milnacipran on the rat serotonergic and noradrenergic systemsTACHIBANA, Kaori; MATSUMOTO, Machiko; KOSEKI, Hiroyo et al.Journal of psychopharmacology (Oxford). 2006, Vol 20, Num 4, pp 562-569, issn 0269-8811, 8 p.Article

Relapse during a 6-month continuation treatment with fluvoxamine in an Italian population : The role of clinical, psychosocial and genetic variablesDOTOLI, Danilo; SPAGNOLO, Chiara; BONGIOMO, Fanny et al.Progress in neuro-psychopharmacology & biological psychiatry. 2006, Vol 30, Num 3, pp 442-448, issn 0278-5846, 7 p.Article

Antidepressant-like effect of coadministration of sulpiride and fluvoxamine in miceAGO, Yukio; HARASAWA, Toshiya; ITOH, Soichi et al.European journal of pharmacology. 2005, Vol 520, Num 1-3, pp 86-90, issn 0014-2999, 5 p.Article

Clinical efficacy of fluvoxamine and functional polymorphism in a serotonin transporter gene on childhood autismSUGIE, Yoko; SUGIE, Hideo; FUKUDA, Tokiko et al.Journal of autism and developmental disorders. 2005, Vol 35, Num 3, pp 377-385, issn 0162-3257, 9 p.Article